Various immune factors, such as atopy and specific immunogenic human leukocyte antigen (HLA) types in asthma patients, as well as genetic factors like mutations in the CF transmembrane conductance regulator (CFTR) gene in CF patients, elevate the susceptibility to ABPA in these populations [1]. This evidence concerns the gene CFTR and asthma.